
GLOBAL PHARMACOVIGILANCE SCHOOL
PROGRAM STRUCTURE

-
Introduction and scope of Pharmacovigilance
-
Good Pharmacovigilance practices (GVP)
-
Adverse Events (AEs)
-
Adverse Drug Reactions (ADRs)
-
Types of Adverse Drug Reactions (ADRs)
-
Product quality complaints (PQCs)
-
Why are pharmacovigilance and reporting ADRs important?
-
Patient Risk Factors for Adverse Drug Reactions
-
Aims and objectives of Pharmacovigilance
-
What is the need of Pharmacovigilance
-
Clinical trials and types
-
Department of Pharmacovigilance & Drug Information
-
Serious adverse reactions criteria with examples
-
ADRs in children
-
ADRs in Pregnant women and in Breastfeeding
-
ADRs in the elderly
-
Pregnancy and congenital abnormalities
-
Adverse incidents involving medical devices
-
Yellow card (Serious warning)
-
Reporting forms of various countries
-
Regulatory Authorities and their roles
-
Validity and essential criteria for an ICSRs reporting
-
Invalid ICSRs and their importance
-
Special reporting situations
-
Expedite reporting
-
Report Types in Pharmacovigilance ICSRs
-
Causality or Causal relationship (Attribution) determinination
-
SUSAR (Suspected unexpected serious adverse reaction)
-
Drug Medication errors
-
Dechallenges and Rechallenges
-
Reference Safety Information (RSIs) documents
-
Reporting timelines and penalties (Practical)
-
Fields or entries related to Pharmacovigilance database (Practical)
-
Age groups and Pharmacovigilance
-
Glossary of Terms
-
Adverse events reporting forms formats (Practical)
-
Examples of adverse events reports and validity (Practical)
-
Narrative writing guidelines (Practical)
-
Narrative formats (Practical)

